These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15703822)

  • 1. Sex-based molecular profiling of hepatitis C virus-related hepatocellular carcinoma.
    Takemoto N; Iizuka N; Yamada-Okabe H; Hamada K; Tamesa T; Okada T; Hashimoto K; Sakamoto K; Takashima M; Miyamoto T; Uchimura S; Hamamoto Y; Oka M
    Int J Oncol; 2005 Mar; 26(3):673-8. PubMed ID: 15703822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
    Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
    Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.
    Satow R; Shitashige M; Kanai Y; Takeshita F; Ojima H; Jigami T; Honda K; Kosuge T; Ochiya T; Hirohashi S; Yamada T
    Clin Cancer Res; 2010 May; 16(9):2518-28. PubMed ID: 20388846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of ID2 associated with invasion of hepatitis C virus-related hepatocellular carcinoma by gene expression profile.
    Tsunedomi R; Iizuka N; Yamada-Okabe H; Tamesa T; Okada T; Sakamoto K; Takashima M; Hamaguchi T; Miyamoto T; Uchimura S; Hamamoto Y; Yamada M; Oka M
    Int J Oncol; 2006 Dec; 29(6):1445-51. PubMed ID: 17088983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization.
    Miyasaka Y; Enomoto N; Nagayama K; Izumi N; Marumo F; Watanabe M; Sato C
    Br J Cancer; 2001 Jul; 85(2):228-34. PubMed ID: 11461082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular signature in three types of hepatocellular carcinoma with different viral origin by oligonucleotide microarray.
    Iizuka N; Oka M; Yamada-Okabe H; Hamada K; Nakayama H; Mori N; Tamesa T; Okada T; Takemoto N; Matoba K; Takashima M; Sakamoto K; Tangoku A; Miyamoto T; Uchimura S; Hamamoto Y
    Int J Oncol; 2004 Mar; 24(3):565-74. PubMed ID: 14767541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.
    Moribe T; Iizuka N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Hamamoto Y; Sakamoto K; Tamesa T; Oka M
    Int J Oncol; 2008 Nov; 33(5):949-58. PubMed ID: 18949357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays.
    Shirota Y; Kaneko S; Honda M; Kawai HF; Kobayashi K
    Hepatology; 2001 Apr; 33(4):832-40. PubMed ID: 11283847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis.
    Wang W; Yang LY; Huang GW; Lu WQ; Yang ZL; Yang JQ; Liu HL
    Br J Cancer; 2004 Jun; 90(12):2349-55. PubMed ID: 15150600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central genetic alterations common to all HCV-positive, HBV-positive and non-B, non-C hepatocellular carcinoma: a new approach to identify novel tumor markers.
    Kurokawa Y; Honma K; Takemasa I; Nakamori S; Kita-Matsuo H; Motoori M; Nagano H; Dono K; Ochiya T; Monden M; Kato K
    Int J Oncol; 2006 Feb; 28(2):383-91. PubMed ID: 16391793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression and clinical significance of hepatocellular cancer antigen genes in human hepatocellular carcinoma].
    Wang WX; Leng XS; Peng JR; Mu DC; Wang Y; Zhu JY; Du RY; Chen WF
    Zhonghua Wai Ke Za Zhi; 2003 Jul; 41(7):506-8. PubMed ID: 12921655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
    Yoon SY; Kim JM; Oh JH; Jeon YJ; Lee DS; Kim JH; Choi JY; Ahn BM; Kim S; Yoo HS; Kim YS; Kim NS
    Int J Oncol; 2006 Aug; 29(2):315-27. PubMed ID: 16820872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method.
    Iizuka N; Oka M; Yamada-Okabe H; Mori N; Tamesa T; Okada T; Takemoto N; Tangoku A; Hamada K; Nakayama H; Miyamoto T; Uchimura S; Hamamoto Y
    Cancer Res; 2002 Jul; 62(14):3939-44. PubMed ID: 12124323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of MAGE-B genes in hepatocellular carcinoma].
    Mou DC; Leng XS; Peng JR; Zhao L; Wang WX; Wang Y; Li T; Zhang LG; Huang L; Zhu JY
    Zhonghua Zhong Liu Za Zhi; 2004 Jan; 26(1):40-2. PubMed ID: 15059354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
    Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
    Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of expression of cytochrome P450 genes in progression of hepatitis C virus-associated hepatocellular carcinoma.
    Tsunedomi R; Iizuka N; Hamamoto Y; Uchimura S; Miyamoto T; Tamesa T; Okada T; Takemoto N; Takashima M; Sakamoto K; Hamada K; Yamada-Okabe H; Oka M
    Int J Oncol; 2005 Sep; 27(3):661-7. PubMed ID: 16077914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-organizing-map-based molecular signature representing the development of hepatocellular carcinoma.
    Iizuka N; Oka M; Yamada-Okabe H; Mori N; Tamesa T; Okada T; Takemoto N; Sakamoto K; Hamada K; Ishitsuka H; Miyamoto T; Uchimura S; Hamamoto Y
    FEBS Lett; 2005 Feb; 579(5):1089-100. PubMed ID: 15710396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.
    Murakami Y; Yasuda T; Saigo K; Urashima T; Toyoda H; Okanoue T; Shimotohno K
    Oncogene; 2006 Apr; 25(17):2537-45. PubMed ID: 16331254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential gene expression in distinct virologic types of hepatocellular carcinoma: association with liver cirrhosis.
    Iizuka N; Oka M; Yamada-Okabe H; Mori N; Tamesa T; Okada T; Takemoto N; Hashimoto K; Tangoku A; Hamada K; Nakayama H; Miyamoto T; Uchimura S; Hamamoto Y
    Oncogene; 2003 May; 22(19):3007-14. PubMed ID: 12771952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
    Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.